Physician

Jeffrey M. Josef, M.D.

According to 2025 Medicare claims, Jeffrey Josef, M.D. (NPI: 1326249558) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Rockland, NY. This provider's primary affiliated billing organization is NY RETINA EYE CARE, PLLC (NPI: 1285418079; TIN: 933021677) and primary practice location at 10901-4831.

Josef's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 919 traditional Medicare patients, billed 160,908 HCPCS/CPT codes, and received $4,307,721 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 892 prescription claims across 275 beneficiaries totaling $130,437 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 14 records totaling $530. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$3.4M$6.8M2015 Medicare payment: $3,325,245 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $4,241,528 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $5,389,957 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $6,389,514 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $6,827,699 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $5,974,204 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $6,465,675 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $5,149,784 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $5,620,904 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $4,307,721 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,17617,260$3,325,245
20161,20219,601$4,241,528
20171,19219,840$5,389,957
20181,17121,678$6,389,514
20191,19922,632$6,827,699
202086517,885$5,974,204
20211,02319,429$6,465,675
202298920,577$5,149,784
2023977129,465$5,620,904
2024919160,908$4,307,721

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$74K$148K2015 Drug cost: $115,216 (USD; Tot_Drug_Cst)2016 Drug cost: $114,262 (USD; Tot_Drug_Cst)2017 Drug cost: $132,661 (USD; Tot_Drug_Cst)2018 Drug cost: $139,679 (USD; Tot_Drug_Cst)2019 Drug cost: $136,156 (USD; Tot_Drug_Cst)2020 Drug cost: $147,708 (USD; Tot_Drug_Cst)2021 Drug cost: $143,192 (USD; Tot_Drug_Cst)2022 Drug cost: $147,703 (USD; Tot_Drug_Cst)2023 Drug cost: $125,467 (USD; Tot_Drug_Cst)2024 Drug cost: $130,437 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015210738$115,216
2016238887$114,262
2017243935$132,661
20182671,008$139,679
2019263948$136,156
2020244911$147,708
2021233882$143,192
2022239831$147,703
2023265848$125,467
2024275892$130,437

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye3751,943$119
92014Established patient complete exam of visual system8372,258$116
92134Imaging of retina8992,498$38
J2777Injection, faricimab-svoa, 0.1 mg25381,121$28
92202Extended exam of the back part of the eye with optic nerve drawing533679$14

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost795,491$48,349
CombiganBrimonidine Tartrate/Timolol432,636$19,255
RestasisCyclosporine11790$14,948
RocklatanNetarsudil Mesylat/Latanoprost18771$7,655
TravoprostTravoprost251,425$6,525

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.14$530Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey M. Josef, M.D.?

Tedicare shows public-source Medicare data for Jeffrey M. Josef, M.D. (NPI 1326249558), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey M. Josef, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey M. Josef, M.D.?

Jeffrey M. Josef, M.D. is linked to NY RETINA EYE CARE, PLLC (billing NPI 1285418079) in the available physician profile data.

Does Jeffrey M. Josef, M.D. have Open Payments data?

Jeffrey M. Josef, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.